Ronald Goldberg

2.1k citations
51 papers · 1.2k indexed · h-index 18

Ronald Goldberg

51 papers receiving 1.2k citations

Peers

Ronald Goldberg
Comparison fields: 5 of 113
  • Rheumatology 411
  • Cell Biology 406
  • Equine 39
  • Immunology and Allergy 137
  • Applied Microbiology and Biotechnology 30
Replace Masako Sakamoto with:
Masako Sakamoto Japan
Fiona Fawthrop United Kingdom
Claes Friman Finland
J E Silbert United States
Allen D. Sawitzke United States
Chun Chen China
Sarah N. Lauder United Kingdom
Aaron C. Petrey United States
Jerome Cantor United States
Shin Nieh Taiwan
Ronald Goldberg relative to Masako Sakamoto Japan Masako Sakamoto's profile →
Citations per field
00.5×10×13×
Masako Sakamoto · 1×
Citations per year

Countries citing papers authored by Ronald Goldberg

Since Specialization
Citations

This map shows the geographic impact of Ronald Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Goldberg more than expected).

Fields of papers citing papers by Ronald Goldberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Goldberg. The network helps show where Ronald Goldberg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ronald Goldberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronald Goldberg Line = papers co-authored together Ronald Goldberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20184
2 20179
3 201014
4 20087
5 19995
6 19972
7 19954
8 19949
9 19931
10 19935
11 19936
12 19919
13 19912
14 19913
15 1990163
16 198918
17 198936
18 198710
19 19818
20 198110

About Ronald Goldberg

Ronald Goldberg is a scholar working on Cell Biology, Rheumatology and Immunology and Allergy, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (19 papers), Osteoarthritis Treatment and Mechanisms (17 papers), Protease and Inhibitor Mechanisms (7 papers), Cell Adhesion Molecules Research (7 papers), Glycosylation and Glycoproteins Research (5 papers), Tendon Structure and Treatment (5 papers), Knee injuries and reconstruction techniques (4 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Rheumatology (411 citations), Cell Biology (406 citations) and Equine (39 citations). Ronald Goldberg has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Bryan P. Toole, David Roth, George C. Fuller, Eugene J.‐M.A. Thonar, Robert S. Katz, Paul B. Glickman, J P Huff, Mary Ellen Lenz, Stephen R. Kaplan and John Doughty. Their work appears in journals such as Inflammation Research, Analytical Biochemistry, Journal of Biological Chemistry, Biochemical Pharmacology and The Journal of Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026